Warren Averett Asset Management, LLC Neurocrine Biosciences Inc Transaction History
Warren Averett Asset Management, LLC
- $8.88 Billion
- Q2 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 1,601 shares of NBIX stock, worth $219,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,601Holding current value
$219,385% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.34 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$763 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$612 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$423 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...